Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle Irradiation.
Ontology highlight
ABSTRACT: Targeted α-particle-emitting radionuclides have great potential for the treatment of a broad range of cancers at different stages of progression. A platform that accurately measures cancer cellular sensitivity to α-particle irradiation could guide and accelerate clinical translation. Here, we performed high-content profiling of cellular survival following exposure to α-particles emitted from radium-223 (223Ra) using 28 genetically diverse human tumor cell lines. Significant variation in cellular sensitivity across tumor cells was observed. 223Ra was significantly more potent than sparsely ionizing irradiation, with a median relative biological effectiveness of 10.4 (IQR: 8.4-14.3). Cells that are the most resistant to γ radiation, such as Nrf2 gain-of-function
SUBMITTER: Yard BD
PROVIDER: S-EPMC6825554 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA